13F Insight
DOSSIER · 13F-HR · Q2 2026

Foresite Capital Management V, LLC

$362M in tracked AUM across 9 positions as of Q2 2026.

FC
CIK 0001792206 · last filed Jun 30, 2026
Total AUM
$362M
as of Q2 2026
Holdings
9
—
positions
Whale Score
71
71
strong
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

Foresite Capital Management V, LLC filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
ALMS
ALUMIS INC.
$166M5.9M45.8%02
CGON
CG Oncology, Inc.
$77M1.1M21.2%03
IRON
Disc Medicine, Inc.
$27M374K7.6%04
HIMS
Hims & Hers Health, Inc.
$26M738K7.1%05
N69605108
Pharvaris N.V.
$23M664K6.3%06
EIKN
Eikon Therapeutics, Inc.
$17M1.3M4.8%07
ODTX
Odyssey Therapeutics, Inc.
$13M713K3.7%08
LYEL
Lyell Immunopharma, Inc.
$7M476K1.8%09
NRIX
Nurix Therapeutics, Inc.
$6M265K1.8%

Filing history

2026Q2Jun 30
$362M▲ 120.3%
9 positionsView →2025Q4Dec 31
$164M▲ 2021.9%
7 positionsView →2025Q3Sep 30
$8M▼ 90.4%
1 positionsView →2025Q2Jun 30
$81M▲ 1745.0%
6 positionsLocked2025Q1Mar 31
$4M▼ 96.4%
1 positionsLocked2024Q4Dec 31
$120M▼ 16.5%
6 positionsLocked2024Q3Sep 30
$144M▼ 8.1%
5 positionsLocked2024Q2Jun 30
$157M▲ 47.0%
5 positionsLocked2024Q1Mar 31
$107M▲ 45.2%
5 positionsLocked2023Q4Dec 31
$73M▲ 17.1%
5 positionsLocked2023Q3Sep 30
$63M▼ 54.2%
7 positionsLocked2023Q2Jun 30
$137M▲ 1.2%
10 positionsLocked
Showing 12 of 22